Online citations, reference lists, and bibliographies.
← Back to Search

Chemical Synthesis Of Monodisperse Magnetic Nanoparticles For Sensitive Cancer Detection

S. Sun
Published 2013 · Materials Science

Cite This
Download PDF
Analyze on Scholarcy
Share
This short tutorial review highlights the advance in high temperature solution phase chemical synthesis of monodisperse magnetic nanoparticles (MNPs), especially iron oxide NPs, as contrast enhancement agents for cancer detection by magnetic resonance imaging (MRI). It introduces briefly the unique nanomagnetism of MNPs required for MRI. It then summarizes some typical methods used to prepare monodisperse Fe3O4 and ferrite MFe2O4 MNPs from high temperature organic phase reaction with controlled magnetic properties. It further outlines the chemistry used to make these MNPs biocompatible and target-specific. Finally it presents two examples to demonstrate the MNP control achieved from chemical synthesis for sensitive detection of cancer.
This paper references
10.2174/156802610791384207
Magnetic nanoparticles as both imaging probes and therapeutic agents.
Lise-Marie Lacroix (2010)
10.1039/b801041b
Zinc ferrite nanoparticles as MRI contrast agents.
C. Bárcena (2008)
10.1089/CBR.1999.14.5
Perceptions of Herceptin: a monoclonal antibody for the treatment of breast cancer.
R. Dillman (1999)
10.1002/anie.200800212
High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
Eric J. Werner (2008)
Kraitchman, Iron oxide MR contrast agents for molecular and cellular imaging
D.L.J.W. Bulte (2004)
Brougham, Stable aqueous dispersions of glycopeptide-grafted selectably functionalized magnetic nanoparticles
T. Borase (2013)
10.1002/anie.201208099
Stable aqueous dispersions of glycopeptide-grafted selectably functionalized magnetic nanoparticles.
Tushar Borase (2013)
10.1038/NMAT1251
Ultra-large-scale syntheses of monodisperse nanocrystals
J. Park (2004)
10.1016/S0140-6736(05)66646-9
Expert heads a'rolling
J. Leach (2005)
b without NPs, c with the injection of 300 lg of c(RGDyK)-MC-Fe3O4 NPs; d Prussian blue staining of U87MG tumors in the presence of c(RGDyK)-MC-Fe3O4 NPs
MRI Principles Fig. 5 a Schematic illustration of the D.G. Mitchell (2014)
10.1039/B510982P
Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.
P. Caravan (2006)
RGD and integrins
E. Ruoslahti (1987)
10.1016/S0140-6736(05)66481-1
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).
M. Leach (2005)
10.1002/ANIE.200461665
One-nanometer-scale size-controlled synthesis of monodisperse magnetic iron oxide nanoparticles.
J. Park (2005)
10.1158/0008-5472.CAN-04-1872
Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects.
L. Stabile (2005)
Kellar, Theory of 1/T-1 and 1/T-2 Nmrd profiles of solutions of magnetic nanoparticles
K.E.S.H. Koenig (1995)
10.1126/SCIENCE.2821619
New perspectives in cell adhesion: RGD and integrins.
E. Ruoslahti (1987)
10.1016/j.addr.2012.10.008
New forms of superparamagnetic nanoparticles for biomedical applications.
C. Xu (2013)
10.1038/nbt0807-875
Antibodies cut down to size
R. C. Ladner (2007)
10.1007/s10059-013-0103-0
Magnetic nanoparticles for multi-imaging and drug delivery
Jae-Hyun Lee (2013)
10.1038/nrc2947
Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer
W. Pao (2010)
10.1002/NBM.924
Iron oxide MR contrast agents for molecular and cellular imaging
J. Bulte (2004)
10.1016/S0149-2918(00)88288-0
Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer.
M. Goldenberg (1999)
10.1021/ja802003h
Ultrasmall c(RGDyK)-coated Fe3O4 nanoparticles and their specific targeting to integrin alpha(v)beta3-rich tumor cells.
Jin Xie (2008)
10.1126/SCIENCE.279.5349.377
Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model.
W. Arap (1998)
10.1038/nm1467
Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging
Jaehyun Lee (2007)
10.1021/JA026501X
Size-controlled synthesis of magnetite nanoparticles.
S. Sun (2002)
10.3978/j.issn.2223-4292.2011.08.03
Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application.
Y. Wáng (2011)
Size-controlled synthesis of magnetite nanoparticies
S. H. Sun (2002)
Synthesis, Properties and Applications Ch
K M. Unruh (1996)
a monoclonal antibody for the treatment of breast cancer
R. O. Dillman (1999)
10.1146/ANNUREV.MATSCI.30.1.545
Synthesis and Characterization of Monodisperse Nanocrystals and Close-Packed Nanocrystal Assemblies
C. Murray (2000)
current status of clinical application
Y.-X.J. Wang (2011)
10.1039/c3cs60149h
Magnetic nanoparticles as contrast agents in the diagnosis and treatment of cancer.
J. Gallo (2013)
Introduction to Magnetic Materials (Addison Wesley Publishing
B. D. Cullity (1972)
10.1021/JA0380852
Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles.
S. Sun (2004)
10.1088/0022-3727/36/13/201
TOPICAL REVIEW: Applications of magnetic nanoparticles in biomedicine
Q. Pankhurst (2003)
Monodisperse MFe 2 O 4 ( M ) Fe , Co , Mn ) Nanoparticles
S. Sun
10.1073/pnas.232686499
A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor
A. Jungbluth (2003)
10.1038/NBT0697-542
αv Integrins as receptors for tumor targeting by circulating ligands
R. Pasqualini (1997)
10.1002/nbm.1684
Specific identification of iron oxide‐labeled stem cells using magnetic field hyperthermia and MR thermometry
D. Haddad (2012)
10.1002/MRM.1910340214
Theory of 1/T1 and 1/T2 NMRD profiles of solutions of magnetic nanoparticles
S. Koenig (1995)
10.1146/ANNUREV.CELLBIO.12.1.697
RGD and other recognition sequences for integrins.
E. Ruoslahti (1996)
10.1016/j.addr.2008.03.014
Multifunctional magnetic nanoparticles for targeted imaging and therapy.
J. Mccarthy (2008)
10.1002/9780470386323
Introduction to Magnetic Materials
B. Cullity (1972)
10.1021/ar200090c
Monodisperse magnetic nanoparticles for theranostic applications.
Don N. Ho (2011)
Gullick, A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor
A. A. Jungbluth (2003)
10.1002/anie.200805149
Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles.
Jung-tak Jang (2009)



This paper is referenced by
10.3390/ma12020326
Properties of Cement-Based Composites Modified with Magnetite Nanoparticles: A Review
E. Horszczaruk (2019)
10.25148/etd.FIDC000195
Cobalt Ferrite Nanoparticles Fabricated via Co-precipitation in Air: Overview of Size Control and Magnetic Properties
D. Toledo (2015)
10.7314/APJCP.2014.15.20.8981
Preparation of lysine-coated magnetic Fe2O3 nanoparticles and influence on viability of A549 lung cancer cells.
Yu-Hua Ma (2014)
Synthesis and characterization of Pt1-xPdx nanoparticles and their suitability for NH3 oxidation catalysis
Martin Jensen (2017)
10.1002/smll.201502309
Small is Smarter: Nano MRI Contrast Agents - Advantages and Recent Achievements.
Z. Gao (2016)
10.1039/C4TA05801A
Noble metal-based composite nanomaterials fabricated via solution-based approaches
H. Liu (2015)
10.1002/EJIC.201402721
Glycine–Nitrate Process for the Elaboration of Eu3+‐Doped Gd2O3 Bimodal Nanoparticles for Biomedical Applications
G. Goglio (2015)
Cobalt Ferrite Nanoparticles Fabricated via Co-precipitation in Air : Overview of Size Control and Magnetic Properties
J. Andrian (2017)
10.1002/med.21420
Nanotechnology in Glycomics: Applications in Diagnostics, Therapy, Imaging, and Separation Processes
Erika Dosekova (2017)
10.1016/J.MSEC.2019.109939
Folic acid-conjugated magnetic ordered mesoporous carbon nanospheres for doxorubicin targeting delivery.
L. Chen (2019)
10.1039/C4RA09393C
Magnetic thermosensitive core/shell microspheres: synthesis, characterization and performance in hyperthermia and drug delivery
L. Chen (2014)
Semantic Scholar Logo Some data provided by SemanticScholar